PainReform
PainReform is a specialty pharmaceutical company focused on the large and growing pain market. PainReform licenses and develops new formulations of approved pain therapeutics that offer meaningful clinical benefits to patients and physicians. The company’s lead product, PRF-108, is a sustained release depot of a well-known local anesthetic for the treatment of post medical procedure pain.
Go To Site

INVESTING PARTNER/FUND:

Join Our Mailing ListSign up to receive regular updates from our blog and news about Viola